Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “AstraZeneca”
Sponsor: Amgen
Small-cell Lung Cancer · Extensive Stage Small-cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +21 more
Sponsor: AstraZeneca
Asthma
United States
Sponsor: Eli Lilly and Company
Carcinoma, Non-Small-Cell Lung
United States, Australia, Austria, Belgium, Brazil +24 more
- A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural MesotheliomaTerminated
Sponsor: Dana-Farber Cancer Institute
Mesothelioma
United States
Sponsor: AstraZeneca
Dilated Cardiomyopathy
Netherlands
Sponsor: AstraZeneca
Chronic Lymphocytic Leukemia
Belarus
Sponsor: M.D. Anderson Cancer Center
Recurrent Chronic Lymphocytic Leukemia · Recurrent Small Lymphocytic Lymphoma · Refractory Chronic Lymphocytic Leukemia · Refractory Small Lymphocytic Lymphoma
United States
- Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine CareActive Not Recruiting
Sponsor: AstraZeneca
Asthma
United States
- Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN)Active Not Recruiting
Sponsor: AstraZeneca
Small Cell Lung Carcinoma Extensive Disease
United States, Argentina, Austria, Brazil, Bulgaria +18 more
- A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD EventActive Not Recruiting
Sponsor: AstraZeneca
Cardiovascular Disease
United States, Argentina, Australia, Brazil, Bulgaria +17 more
Sponsor: Jonsson Comprehensive Cancer Center
Carcinoma, Non-Small-Cell Lung
United States, Australia
- A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFHActive Not Recruiting
Sponsor: AstraZeneca
Heterozygous Familial Hypercholesterolaemia
United States, Argentina, Australia, Brazil, Bulgaria +19 more
- Selumetinib for NF2-Related SchwannomatosisNot Yet Recruiting
Sponsor: Beijing Tiantan Hospital
Neurofibromatosis Type 2 · NF2 · NF2-related Schwannomatosis · Meningioma
China
Sponsor: AstraZeneca
Asthma
United States
Sponsor: AstraZeneca
COPD (Chronic Obstructive Pulmonary Disease)
Brazil
Sponsor: AstraZeneca
Non-Small Cell Lung Cancer
United States, Australia, Austria, Belgium, Brazil +16 more
Sponsor: AstraZeneca
Type 2 Diabetes Mellitus
United States, Argentina, Brazil, China, Czechia +18 more
- Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate CancerRecruiting
Sponsor: AstraZeneca
Metastatic Prostate Cancer
United States, Brazil, China, France, Italy +5 more
- Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the BladderActive Not Recruiting
Sponsor: Noah Hahn, M.D.
Urothelial Carcinoma · Bladder Cancer
United States
Sponsor: AstraZeneca
Type 2 Diabetes Mellitus · Type 2 Diabetes With Chronic Kidney Disease
United States, Bulgaria, China, Denmark, Germany +11 more
- A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular CarcinomaActive Not Recruiting
Sponsor: AstraZeneca
Hepatocellular Carcinoma
United States, Australia, Brazil, Canada, China +13 more
Sponsor: AstraZeneca
Solid Tumours
United States, Australia, Japan, South Korea, Spain +1 more
Sponsor: AstraZeneca
Type 2 Diabetes Mellitus
United States, Argentina, China, Denmark, Greece +8 more
Sponsor: AstraZeneca
Chronic Obstructive Pulmonary Disease (COPD)
United States, Argentina, Australia, Bulgaria, Canada +19 more
Sponsor: AstraZeneca
Rare Diseases · Generalized Myasthenia Gravis (gMG)
Russia